MBCCOP HOME NCI

Keith A. Dookeran
Assistant Professor of Surgical Oncology at the University of Illinois at Chicago
Community Scientific Adviser for the SHCC Minority-Based Community Clinical Oncology Program

Keith A. Dookeran MD Keith A. Dookeran MBBS FRCS(Ed), is a Surgical Oncologist dedicated to a practice in breast cancer with a special focus on issues regarding minority, elderly and underserved women. He provides specialist care for this vulnerable group of women with breast cancer and has worked to improve their access to techniques for early diagnosis, including image-guided breast biopsy procedures with ultrasound, and also to partial breast radiation oncology techniques with the MammoSite device, which shortens time for treatment in elderly women, and also for those with restricted mobility.

He has been an advocate for their concerns and has presented his work and contributions at the American Association of Cancer Research, the American Society of Clinical Oncology, the San Antonio Breast Cancer Symposium and the Avon Foundation. He has a major interest in evaluation of tumor biology and poverty as causes of worse survival and outcome disparity from breast cancer in minority and underserved women. He is dedicated to helping these women gain access to National Cancer Institute clinical research studies for treatment and prevention of breast cancer, since their participation allows access to new drugs and technology and help to increase the overall understanding of breast cancer as a disease in minority and underserved women.

Websites & links related to Dr. Dookeran’s work

Selected recent abstracts & publications

  • June 2006: p53 expression in breast cancer is more likely to predict survival in African-American than Hispanic or white women. The 2006 Annual meeting of the American Society of Clinical Oncology, Atlanta, GA. [ASCO.org]
  • April 2006: Underserved African-American & white women with breast cancer have similar prognostic profiles for estrogen receptor and tumor grade. The 97th annual meeting of the American Association for Cancer Research, Washington, DC. [AbstractsOnLine.com]
  • December 2005: Low socio-economic status African-American, Hispanic White women with breast cancer demonstrate similar hormone receptor status, tumor grade survival. The 28th Annual San Antonio Breast Cancer Symposium, San Antonio, TX. [Abstracts2View.com]
  • April 2005: Health attitudes, beliefs and habits affect breast cancer screening practice among minority-underserved and low income women. The 96th annual meeting of the American Association for Cancer Research, Anaheim, CA.
  • April 2005: HER2/neu overexpression and survival in African-American women with breast cancer. The 96th annual meeting of the American Association for Cancer Research, Anaheim, CA.
  • December 2004: Analysis of hormone receptor function in African-American women with breast cancer. The 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.
  • December 2004: Improved yield of perioperative screening for metastases in African-American women with operable breast cancer. The 27th Annual San Antonio Breast Cancer Symposium, San Antonio, TX.
  • March 2004: Poor Quality Reporting of Screening Mammography is Associated with Lower Rates of Diagnosis of Early-Stage Breast Cancer in Minority-Underserved Women. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.
  • March 2004: Early Stage Interval Breast Cancers in African-American Women Demonstrate ER Negative Status & More Aggressive Tumor Biology. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.
  • March 2004: HER2/neu Status in African-American Women with Breast Cancer. The 95th annual meeting of the American Association for Cancer Research, Orlando, FL.